Enterprise Therapeutics

Summary

Seedtable Score

64

Locations

• London

Company Size

• 11 - 51

Last Stage Round

• Series B

Industry

• Biotech
• Health Tech

• Series A (2015) $2.0M

---

• Series B (2018-12-01) $36.6M

---

Investors

• Epidarex Capital Series A

---

• Epidarex Capital Series A

---

• Imperial Innovations Series A

---

• Forbion Capital Partners Series B

---

• Forbion Capital Partners Series B

---

• Novartis Venture Fund Series B

---

• Panakes Partners Series B

---

• IP Group Series B

---

• Versant Ventures Series B

---

• Versant Ventures Series B

---

Full Company Profile

Access details of the company management, and other intelligence on this company by registering for Seedtable

---